These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
167 related items for PubMed ID: 1723801
1. The neurochemical and stimulatory effects of putative metabolites of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine in rats. Yeh SY, Hsu FL. Pharmacol Biochem Behav; 1991 Jul; 39(3):787-90. PubMed ID: 1723801 [Abstract] [Full Text] [Related]
2. 2,5-Bis-(glutathion-S-yl)-alpha-methyldopamine, a putative metabolite of (+/-)-3,4-methylenedioxyamphetamine, decreases brain serotonin concentrations. Miller RT, Lau SS, Monks TJ. Eur J Pharmacol; 1997 Apr 04; 323(2-3):173-80. PubMed ID: 9128836 [Abstract] [Full Text] [Related]
3. Glutathione and N-acetylcysteine conjugates of alpha-methyldopamine produce serotonergic neurotoxicity: possible role in methylenedioxyamphetamine-mediated neurotoxicity. Bai F, Lau SS, Monks TJ. Chem Res Toxicol; 1999 Dec 04; 12(12):1150-7. PubMed ID: 10604863 [Abstract] [Full Text] [Related]
4. Caffeine promotes hyperthermia and serotonergic loss following co-administration of the substituted amphetamines, MDMA ("Ecstasy") and MDA ("Love"). McNamara R, Kerans A, O'Neill B, Harkin A. Neuropharmacology; 2006 Jan 04; 50(1):69-80. PubMed ID: 16188283 [Abstract] [Full Text] [Related]
5. A pharmacokinetic analysis of 3,4-methylenedioxymethamphetamine effects on monoamine concentrations in brain dialysates. Hiramatsu M, DiStefano E, Chang AS, Cho AK. Eur J Pharmacol; 1991 Nov 05; 204(2):135-40. PubMed ID: 1725282 [Abstract] [Full Text] [Related]
6. (+/-)3,4-Methylenedioxymethamphetamine (MDMA) produces long-term reductions in brain 5-hydroxytryptamine in rats. Mokler DJ, Robinson SE, Rosecrans JA. Eur J Pharmacol; 1987 Jun 19; 138(2):265-8. PubMed ID: 2887440 [Abstract] [Full Text] [Related]
7. 5-HT loss in rat brain following 3,4-methylenedioxymethamphetamine (MDMA), p-chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine. Colado MI, Murray TK, Green AR. Br J Pharmacol; 1993 Mar 19; 108(3):583-9. PubMed ID: 7682129 [Abstract] [Full Text] [Related]
8. Major metabolites of (+/-)3,4-methylenedioxyamphetamine (MDA) do not mediate its toxic effects on brain serotonin neurons. McCann UD, Ricaurte GA. Brain Res; 1991 Apr 05; 545(1-2):279-82. PubMed ID: 1860050 [Abstract] [Full Text] [Related]
9. 3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites. Battaglia G, Yeh SY, O'Hearn E, Molliver ME, Kuhar MJ, De Souza EB. J Pharmacol Exp Ther; 1987 Sep 05; 242(3):911-6. PubMed ID: 2443644 [Abstract] [Full Text] [Related]
16. Synthesis, in vitro formation, and behavioural effects of glutathione regioisomers of alpha-methyldopamine with relevance to MDA and MDMA (ecstasy). Easton N, Fry J, O'Shea E, Watkins A, Kingston S, Marsden CA. Brain Res; 2003 Oct 17; 987(2):144-54. PubMed ID: 14499958 [Abstract] [Full Text] [Related]
18. Effects of intracerebroventricular administration of 5-(glutathion-S-yl)-alpha-methyldopamine on brain dopamine, serotonin, and norepinephrine concentrations in male Sprague-Dawley rats. Miller RT, Lau SS, Monks TJ. Chem Res Toxicol; 1996 Mar 17; 9(2):457-65. PubMed ID: 8839050 [Abstract] [Full Text] [Related]